|
⚲
|
| Keyboard |
| Two Sigma Ventures LP
✚
|
|
|---|---|
| CRD # | 295416 |
| SEC # | 801-113886 |
| CIK # | 0001878979 |
| AUM | 2,226.1 M (2026-03-31) |
| Employees | 36 (39% Investors, 0% Brokers) |
| Phone | 212-625-5700 |
| Address | 100 Avenue of The Americas New York, NY 10013-1689 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Recursion Pharmaceuticals Inc | 9.6 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Two Sigma Ventures Co-Invest Fund LLC - Investment Series 10 | [2023-03-31] | 0.8 M | 0.6 M |
| Offered $835,858 · Filed 2022-10-07 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Two Sigma Ventures Co-Invest Fund LLC - Investment Series 8 | [2023-03-31] | 0.7 M | 0.4 M |
| Offered $709,192 · Filed 2022-02-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Two Sigma Ventures Co-Invest Fund LLC - Investment Series 9 | [2023-03-31] | 1.8 M | 1.4 M |
| Offered $1,838,833 · Filed 2022-02-03 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Two Sigma Ventures IV LP | [2023-03-31] | 500.2 M | |
| Filed 2022-01-26 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Two Sigma Ventures Maple Fund I LP | [2023-03-31] | 93.4 M | |
| Filed 2022-06-29 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Two Sigma Ventures Opportunity Fund II LP | [2023-03-31] | 90.8 M | |
| Filed 2022-01-26 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Two Sigma Ventures Co-Invest Fund LLC - Investment Series 6 | [2022-03-31] | 2.2 M | 1.4 M |
| Offered $2,176,510 · Filed 2021-04-01 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Two Sigma Ventures Co-Invest Fund LLC - Investment Series 7 | [2022-03-31] | 1.7 M | 1.3 M |
| Offered $1,654,950 · Filed 2021-06-23 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Two Sigma Ventures Opportunity Fund LP | [2022-03-31] | 40.0 M | |
| Filed 2021-02-10 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Two Sigma Ventures Co-Invest Fund LLC - Investment Series 3 | [2021-03-30] | 2.0 M | 3.9 M |
| Offered $2,046,120 · Filed 2020-06-04 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 15 | 2.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 15 | 2.2 |
| By Discretionary | ||
| Discretionary | 15 | 2.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 15 | 2.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 2.2 | |
| Total | 15 | 2.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Two Sigma Principals LLC | Promoter | 30 | 4 | |
| Matthew Siano | Executive Officer | 24 | 4 | |
| Jeremy Rossman | Executive Officer | 23 | 4 | |
| Wray Thorn | Executive Officer | 17 | 3 | |
| Joseph Majocha | Executive Officer | 8 | 3 | |
| Christian Diez | Executive Officer | 8 | 3 | |
| Colin Beirne | Executive Officer | 22 | 2 | |
| Daniel Abelon | Executive Officer | 18 | 2 | |
| Velislav Iltchev | Executive Officer | 12 | 2 | |
| Villi Iltchev | Executive Officer | 12 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001878979] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
Wil LLC
✚
|
CA | 2,265.8 M |
|
Excellere Capital Management LLC
✚
|
CO | 2,255.4 M |
|
APC Asset Development I LP
✚
|
CA | 2,250.6 M |
|
Hidden Harbor Capital Management LP
✚
|
FL | 2,235.2 M |
|
EIV Capital LLC
✚
|
TX | 2,232.2 M |
|
CCMP Capital Advisors LP
✚
|
NY | 2,229.0 M |
|
Longrange Capital LP
✚
|
CT | 2,219.6 M |
|
Further Global Capital Management LP
✚
|
NY | 2,215.6 M |
|
CR Group LP
✚
|
TX | 2,207.6 M |
|
Kosmos Management LLC
✚
|
WA | 2,205.9 M |